The U.S. Food and Drug Administration gave De Novo clearance to Techsomed's BioTraceIO, which leverages a computational algorithm to analyze ultrasound images captured during liver ablation treatment ...

Chicago — Surgical resection is the standard of care for small colorectal liver metastases, but the results of a phase 3 trial reported at the American Society of Clinical Oncology (ASCO) 2024 annual ...

French developer Quantum Surgical has scored an FDA clearance for its robot designed specifically to target liver cancer. The company’s Epione system helps plan and perform minimally invasive ablation ...

Surgery and radiofrequency ablation showed similar 5-year survival rates for small liver tumors. Both treatments had nearly identical 5-year recurrence-free survival outcomes. Patient and tumor ...

The National Institute for Clinical Excellence is examining radiofrequency ablation of liver tumours and will publish guidance on its safety and efficacy for the NHS in England and Wales. The ...

AngioDynamics ANGO recently announced expanded indications in Europe for its NanoKnife System, broadening its clinical utility in soft tissue tumor ablation. The expanded approval covers NanoKnife’s ...

Liver metastases are most commonly caused by colorectal cancer but may also result from other malignancies, such as lung and gastric cancer. Treatment of liver metastases depends on their extent and ...

Biologically optimized schedule of gemcitabine and nab-paclitaxel regimen in metastatic pancreatic adenocarcinoma. Background: Pancreatic cancer represents one of the most aggressive tumors and the ...

Parenchymal-sparing liver resection with microwave ablation is safe and effective for patients who have neuroendocrine tumors (NETs) and a high number of liver metastases; the treatment has no effect ...